Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (4)
Type
Type
Guidance (890)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (21)
Antimicrobial resistance guidance (2)
Cancer service guidelines (5)
Clinical guidelines (229)
COVID-19 rapid guidelines (8)
HealthTech guidance (769)
Highly specialised technologies guidance (30)
Medicines practice guidelines (5)
NICE guidelines (336)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (69)
Technology appraisal guidance (890)
Apply filters
Showing 851 to 875 of 890
Sort by
Date
Title
Apply sorting
Guidance programme: Technology appraisal guidance
`Remove $Guidance programme: Technology appraisal guidance filter`
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus
TA151
23 July 2008
23 July 2008
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck
TA145
25 June 2008
25 June 2008
Adalimumab for treating moderate to severe plaque psoriasis
TA146
25 June 2008
25 June 2008
Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal)
TA148
25 June 2008
25 June 2008
Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal)
TA149
25 June 2008
25 June 2008
Structural neuroimaging in first-episode psychosis
TA136
27 February 2008
27 February 2008
Rituximab for the treatment of relapsed or refractory stage 3 or 4 follicular non-Hodgkin's lymphoma
TA137
27 February 2008
27 February 2008
Infliximab for treating moderate to severe plaque psoriasis
TA134
23 January 2008
23 January 2008
Pemetrexed for the treatment of malignant pleural mesothelioma
TA135
23 January 2008
23 January 2008
Bortezomib monotherapy for relapsed multiple myeloma
TA129
23 October 2007
23 October 2007
Stapled haemorrhoidopexy for the treatment of haemorrhoids
TA128
26 September 2007
26 September 2007
Pemetrexed for the treatment of non-small-cell lung cancer
TA124
22 August 2007
22 August 2007
Varenicline for smoking cessation
TA123
25 July 2007
25 July 2007
Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma
TA121
27 June 2007
27 June 2007
Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia
TA119
28 February 2007
28 February 2007
Methadone and buprenorphine for the management of opioid dependence
TA114
24 January 2007
24 January 2007
Naltrexone for the management of opioid dependence
TA115
24 January 2007
24 January 2007
Gemcitabine for the treatment of metastatic breast cancer
TA116
24 January 2007
24 January 2007
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy
TA117
24 January 2007
24 January 2007
Laparoscopic surgery for colorectal cancer
TA105
23 August 2006
23 August 2006
Docetaxel for the treatment of hormone-refractory metastatic prostate cancer
TA101
28 June 2006
28 June 2006
Capecitabine and oxaliplatin in the adjuvant treatment of stage 3 (Dukes' C) colon cancer
TA100
26 April 2006
26 April 2006
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B
TA96
22 February 2006
22 February 2006
HealOzone for the treatment of tooth decay (occlusal pit and fissure caries and root caries)
TA92
27 July 2005
27 July 2005
Guidance on the use of paclitaxel in the treatment of ovarian cancer
TA55
22 January 2003
1 May 2005
Previous page
1
…
33
34
Current page
35
36
Page
35
of
36
Next page
Results per page
10
25
50
All
Back to top